Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies

Yin Wu; Brooke Levis; Ying Sun; Ankur Krishnan; Chen He; Kira E. Riehm; Danielle B. Rice; Marleine Azar; Xin Wei Yan; Dipika Neupane; Parash Mani Bhandari; Mahrukh Imran; Matthew J. Chiovitti; Nazanin Saadat; Jill T. Boruff; Pim Cuijpers; Simon Gilbody; Dean McMillan; John P.A. Ioannidis; Lorie A. Kloda; Scott B. Patten; Ian Shrier; Roy C. Ziegelstein; Melissa Henry; Zahinoor Ismail; Carmen G. Loiselle; Nicholas D. Mitchell; Marcello Tonelli; Samir Al-Adawi; Anna Beraldi; Anna P.B.M. Braeken; Natalie Büel-Drabe; Adomas Bunevicius; Gregory Carter; Chih Ken Chen; Gary Cheung; Kerrie Clover; Ronán M. Conroy; Daniel Cukor; Carlos E. da Rocha e Silva; Eli Dabscheck; Federico M. Daray; Elles Douven; Marina G. Downing; Anthony Feinstein; Panagiotis P. Ferentinos; Felix H. Fischer; Alastair J. Flint; Maiko Fujimori; Pamela Gallagher; Milena Gandy; Simone Goebel; Luigi Grassi; Martin Härter; Josef Jenewein; Nathalie Jetté; Miguel Julião; Jae Min Kim; Sung Wan Kim; Marie Kjærgaard; Sebastian Köhler; Wim L. Loosman; Bernd Löwe; Rocio Martin-Santos; Loreto Massardo; Yutaka Matsuoka; Anja Mehnert; Ioannis Michopoulos; Laurent Misery; Ricard Navines; Meaghan L. O'Donnell; Ahmet Öztürk; Jurate Peceliuniene; Luis Pintor; Jennie L. Ponsford; Terence J. Quinn; Silje E. Reme; Katrin Reuter; Alasdair G. Rooney; Roberto Sánchez-González; Marcelo L. Schwarzbold; Vesile Senturk Cankorur; Juwita Shaaban; Louise Sharpe; Michael Sharpe; Sébastien Simard; Susanne Singer; Lesley Stafford; Jon Stone; Serge Sultan; Antonio L. Teixeira; Istvan Tiringer; Alyna Turner; Jane Walker; Mark Walterfang; Liang Jen Wang; Jennifer White; Dana K. Wong; Andrea Benedetti; Brett D. Thombs

doi:10.1016/j.jpsychores.2019.109892

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies

Yin Wu, Brooke Levis, Ying Sun, Ankur Krishnan, Chen He, Kira E. Riehm, Danielle B. Rice, Marleine Azar, Xin Wei Yan, Dipika Neupane, Parash Mani Bhandari, Mahrukh Imran, Matthew J. Chiovitti, Nazanin Saadat, Jill T. Boruff, Pim Cuijpers, Simon Gilbody, Dean McMillan, John P.A. Ioannidis, Lorie A. KlodaScott B. Patten, Ian Shrier, Roy C. Ziegelstein, Melissa Henry, Zahinoor Ismail, Carmen G. Loiselle, Nicholas D. Mitchell, Marcello Tonelli, Samir Al-Adawi, Anna Beraldi, Anna P.B.M. Braeken, Natalie Büel-Drabe, Adomas Bunevicius, Gregory Carter, Chih Ken Chen, Gary Cheung, Kerrie Clover, Ronán M. Conroy, Daniel Cukor, Carlos E. da Rocha e Silva, Eli Dabscheck, Federico M. Daray, Elles Douven, Marina G. Downing, Anthony Feinstein, Panagiotis P. Ferentinos, Felix H. Fischer, Alastair J. Flint, Maiko Fujimori, Pamela Gallagher, Milena Gandy, Simone Goebel, Luigi Grassi, Martin Härter, Josef Jenewein, Nathalie Jetté, Miguel Julião, Jae Min Kim, Sung Wan Kim, Marie Kjærgaard, Sebastian Köhler, Wim L. Loosman, Bernd Löwe, Rocio Martin-Santos, Loreto Massardo, Yutaka Matsuoka, Anja Mehnert, Ioannis Michopoulos, Laurent Misery, Ricard Navines, Meaghan L. O'Donnell, Ahmet Öztürk, Jurate Peceliuniene, Luis Pintor, Jennie L. Ponsford, Terence J. Quinn, Silje E. Reme, Katrin Reuter, Alasdair G. Rooney, Roberto Sánchez-González, Marcelo L. Schwarzbold, Vesile Senturk Cankorur, Juwita Shaaban, Louise Sharpe, Michael Sharpe, Sébastien Simard, Susanne Singer, Lesley Stafford, Jon Stone, Serge Sultan, Antonio L. Teixeira, Istvan Tiringer, Alyna Turner, Jane Walker, Mark Walterfang, Liang Jen Wang, Jennifer White, Dana K. Wong, Andrea Benedetti^*, Brett D. Thombs

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Methods: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. Results: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). Conclusion: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.

Original language	English
Article number	109892
Journal	Journal of Psychosomatic Research
Volume	129
Early online date	13 Dec 2019
DOIs	https://doi.org/10.1016/j.jpsychores.2019.109892
Publication status	Published - 3 Jan 2020

Bibliographical note

Funding Information:
All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years with the following exceptions: (1) Dr. Patten declares that he has received a grant, from the University of Calgary Hotchkiss Brain Institute, which was jointly funded by the Institute and Pfizer, outside the submitted work. (2) Dr. Ismail declares that he has received personal fees from Avanir, Janssen, Lundbeck, Otsuka, Sunovion, outside the submitted work. (3) Dr. Tonelli declares that he has received a grant from Merck Canada, outside the submitted work. (4) Dr. Feinstein reports that he received speaker's honorariums from Biogen, Sanofi-Genzyme, Merck-Serono, Novartis, Roche, and is on the advisory board for Akili Interactive, outside the submitted work; He has also received royalties from the Cambridge University Press for the Clinical Neuropsychiatry of Multiple Sclerosis, 2nd Edition. (5) Dr. Jetté declares that she has received grants, from University of Calgary Hotchkiss Brain Institute, which was partly funded by Mathison Health Centre and Pfizer, outside the submitted work. (6) Dr. Löwe declares that the primary study by Löwe et al. was supported by unrestricted educational grants from Pfizer, Germany. (7) Dr. Matsuoka declares that he has received personal fees from Mochida, Pfizer, Eli Lilly, Morinaga Milk, and NTT Data, outside the submitted work. (8) Dr. Stone declares that he has received personal fees from UptoDate, outside the submitted work. (9) Dr. Sultan declares funding from Sanofi-Aventis Corporation, during conduct of the primary study.

Funding Information:
This study was funded by the Canadian Institutes of Health Research (CIHR, KRS-144045 & PCG 155468). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada. Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre. Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions. The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust, and funding from the Hotchkiss Brain Institute. The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine, and the Hotchkiss Brain Institute. The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania (LIG-03/2011). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958?2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan (NSC 96-2314-B-182A-090-MY2). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland, the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund. The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association. The primary study by De la Torre et al. was supported by a Research Grant ?Ram?n Carrillo-Arturo O?ativa for Multicentric Studies? (2015) from the commission ?Salud Investiga? of the Ministry of Health and Social Action of Argentina (Grant n? 1853). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg, and the Adriana van Rinsum-Ponsen Stichting. The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada. The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research (01GY1150). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network. The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9?31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara ? SI2.307317 2000CVGG2?026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by H?rter et al. was supported by the Federal Ministry of Education and Research, the Federation of German Pension Insurance Institutes, and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea. The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0087344), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by L?we et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III (EO PI08/90869) and (PSIGEN-VHC Study: FIS-E08/00268). The primary study by Massardo et al. was supported by Comisi?n Nacional de Investigaci?n Cient?fica y Tecnol?gica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Cient?fico y Tecnol?gico (FONDECYT; grant # 1110849). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health (16190501, 19230701 and 20300701). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain (PI040418) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a ?start-up? research grant from the British Geriatric Society, Scotland. The primary study by Reme et al. was supported by the Research Council of Norway. The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund. The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Funda?ao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM). The primary study by Azah et al. was supported by Universiti Sains Malaysia. The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance, as well as a studentship from the Canadian Institutes of Health Research. The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX) and of the University of Leipzig (# formel. 1-57). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF). The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne. The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland. The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil. The primary study by Pedroso et al. was supported by FAPEMIG (APq-03539-13). The primary study by Pedroso et al. was supported by Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council (ETT 395). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute. The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards.

Funding Information:
This study was funded by the Canadian Institutes of Health Research (CIHR , KRS-144045 & PCG 155468 ). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada . Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre . Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions . The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust , and funding from the Hotchkiss Brain Institute . The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine , and the Hotchkiss Brain Institute . The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania ( LIG-03/2011 ). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958–2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan ( NSC 96-2314-B-182A-090-MY2 ). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland , the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund . The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association . The primary study by De la Torre et al. was supported by a Research Grant “Ramón Carrillo-Arturo Oñativa for Multicentric Studies” (2015) from the commission “Salud Investiga” of the Ministry of Health and Social Action of Argentina (Grant n° 1853 ). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg , and the Adriana van Rinsum-Ponsen Stichting . The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada . The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research ( 01GY1150 ). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network . The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology . The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9–31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL ). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara — SI2.307317 2000CVGG2–026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by Härter et al. was supported by the Federal Ministry of Education and Research , the Federation of German Pension Insurance Institutes , and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4 ). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000 ). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea . The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology ( 2009-0087344 ), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by Löwe et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III ( EO PI08/90869 ) and ( PSIGEN-VHC Study : FIS-E08/00268 ). The primary study by Massardo et al. was supported by Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Científico y Tecnológico (FONDECYT ; grant # 1110849 ). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health ( 16190501 , 19230701 and 20300701 ). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465 ). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain ( PI040418 ) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a ‘start-up’ research grant from the British Geriatric Society, Scotland . The primary study by Reme et al. was supported by the Research Council of Norway . The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund . The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundaçao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM) . The primary study by Azah et al. was supported by Universiti Sains Malaysia . The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance , as well as a studentship from the Canadian Institutes of Health Research . The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106 ). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX ) and of the University of Leipzig (# formel. 1-57 ). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF) . The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne . The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland . The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil . The primary study by Pedroso et al. was supported by FAPEMIG ( APq-03539-13 ). The primary study by Pedroso et al. was supported by Fundação de Amparo à Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council ( ETT 395 ). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute . The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards.

Publisher Copyright:
© 2019 Elsevier Inc.

Keywords

Depressive disorders
Diagnostic interviews
Hospital Anxiety and Depression Scale
Individual participant data meta-analysis
Major depression

Access to Document

10.1016/j.jpsychores.2019.109892

Cite this

Wu, Y., Levis, B., Sun, Y., Krishnan, A., He, C., Riehm, K. E., Rice, D. B., Azar, M., Yan, X. W., Neupane, D., Bhandari, P. M., Imran, M., Chiovitti, M. J., Saadat, N., Boruff, J. T., Cuijpers, P., Gilbody, S., McMillan, D., Ioannidis, J. P. A., ... Thombs, B. D. (2020). Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. Journal of Psychosomatic Research, 129, Article 109892. https://doi.org/10.1016/j.jpsychores.2019.109892

@article{6187c4ff34b346b995abbde1bc92dbf1,

title = "Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies",

abstract = "Objective: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Methods: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. Results: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). Conclusion: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.",

keywords = "Depressive disorders, Diagnostic interviews, Hospital Anxiety and Depression Scale, Individual participant data meta-analysis, Major depression",

author = "Yin Wu and Brooke Levis and Ying Sun and Ankur Krishnan and Chen He and Riehm, {Kira E.} and Rice, {Danielle B.} and Marleine Azar and Yan, {Xin Wei} and Dipika Neupane and Bhandari, {Parash Mani} and Mahrukh Imran and Chiovitti, {Matthew J.} and Nazanin Saadat and Boruff, {Jill T.} and Pim Cuijpers and Simon Gilbody and Dean McMillan and Ioannidis, {John P.A.} and Kloda, {Lorie A.} and Patten, {Scott B.} and Ian Shrier and Ziegelstein, {Roy C.} and Melissa Henry and Zahinoor Ismail and Loiselle, {Carmen G.} and Mitchell, {Nicholas D.} and Marcello Tonelli and Samir Al-Adawi and Anna Beraldi and Braeken, {Anna P.B.M.} and Natalie B{\"u}el-Drabe and Adomas Bunevicius and Gregory Carter and Chen, {Chih Ken} and Gary Cheung and Kerrie Clover and Conroy, {Ron{\'a}n M.} and Daniel Cukor and {da Rocha e Silva}, {Carlos E.} and Eli Dabscheck and Daray, {Federico M.} and Elles Douven and Downing, {Marina G.} and Anthony Feinstein and Ferentinos, {Panagiotis P.} and Fischer, {Felix H.} and Flint, {Alastair J.} and Maiko Fujimori and Pamela Gallagher and Milena Gandy and Simone Goebel and Luigi Grassi and Martin H{\"a}rter and Josef Jenewein and Nathalie Jett{\'e} and Miguel Juli{\~a}o and Kim, {Jae Min} and Kim, {Sung Wan} and Marie Kj{\ae}rgaard and Sebastian K{\"o}hler and Loosman, {Wim L.} and Bernd L{\"o}we and Rocio Martin-Santos and Loreto Massardo and Yutaka Matsuoka and Anja Mehnert and Ioannis Michopoulos and Laurent Misery and Ricard Navines and O'Donnell, {Meaghan L.} and Ahmet {\"O}zt{\"u}rk and Jurate Peceliuniene and Luis Pintor and Ponsford, {Jennie L.} and Quinn, {Terence J.} and Reme, {Silje E.} and Katrin Reuter and Rooney, {Alasdair G.} and Roberto S{\'a}nchez-Gonz{\'a}lez and Schwarzbold, {Marcelo L.} and {Senturk Cankorur}, Vesile and Juwita Shaaban and Louise Sharpe and Michael Sharpe and S{\'e}bastien Simard and Susanne Singer and Lesley Stafford and Jon Stone and Serge Sultan and Teixeira, {Antonio L.} and Istvan Tiringer and Alyna Turner and Jane Walker and Mark Walterfang and Wang, {Liang Jen} and Jennifer White and Wong, {Dana K.} and Andrea Benedetti and Thombs, {Brett D.}",

note = "Funding Information: All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years with the following exceptions: (1) Dr. Patten declares that he has received a grant, from the University of Calgary Hotchkiss Brain Institute, which was jointly funded by the Institute and Pfizer, outside the submitted work. (2) Dr. Ismail declares that he has received personal fees from Avanir, Janssen, Lundbeck, Otsuka, Sunovion, outside the submitted work. (3) Dr. Tonelli declares that he has received a grant from Merck Canada, outside the submitted work. (4) Dr. Feinstein reports that he received speaker's honorariums from Biogen, Sanofi-Genzyme, Merck-Serono, Novartis, Roche, and is on the advisory board for Akili Interactive, outside the submitted work; He has also received royalties from the Cambridge University Press for the Clinical Neuropsychiatry of Multiple Sclerosis, 2nd Edition. (5) Dr. Jett{\'e} declares that she has received grants, from University of Calgary Hotchkiss Brain Institute, which was partly funded by Mathison Health Centre and Pfizer, outside the submitted work. (6) Dr. L{\"o}we declares that the primary study by L{\"o}we et al. was supported by unrestricted educational grants from Pfizer, Germany. (7) Dr. Matsuoka declares that he has received personal fees from Mochida, Pfizer, Eli Lilly, Morinaga Milk, and NTT Data, outside the submitted work. (8) Dr. Stone declares that he has received personal fees from UptoDate, outside the submitted work. (9) Dr. Sultan declares funding from Sanofi-Aventis Corporation, during conduct of the primary study. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR, KRS-144045 & PCG 155468). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada. Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre. Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions. The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust, and funding from the Hotchkiss Brain Institute. The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine, and the Hotchkiss Brain Institute. The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania (LIG-03/2011). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958?2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan (NSC 96-2314-B-182A-090-MY2). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland, the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund. The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association. The primary study by De la Torre et al. was supported by a Research Grant ?Ram?n Carrillo-Arturo O?ativa for Multicentric Studies? (2015) from the commission ?Salud Investiga? of the Ministry of Health and Social Action of Argentina (Grant n? 1853). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg, and the Adriana van Rinsum-Ponsen Stichting. The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada. The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research (01GY1150). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network. The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9?31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara ? SI2.307317 2000CVGG2?026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by H?rter et al. was supported by the Federal Ministry of Education and Research, the Federation of German Pension Insurance Institutes, and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea. The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0087344), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by L?we et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III (EO PI08/90869) and (PSIGEN-VHC Study: FIS-E08/00268). The primary study by Massardo et al. was supported by Comisi?n Nacional de Investigaci?n Cient?fica y Tecnol?gica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Cient?fico y Tecnol?gico (FONDECYT; grant # 1110849). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health (16190501, 19230701 and 20300701). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain (PI040418) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a ?start-up? research grant from the British Geriatric Society, Scotland. The primary study by Reme et al. was supported by the Research Council of Norway. The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund. The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Funda?ao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM). The primary study by Azah et al. was supported by Universiti Sains Malaysia. The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance, as well as a studentship from the Canadian Institutes of Health Research. The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX) and of the University of Leipzig (# formel. 1-57). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF). The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne. The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland. The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil. The primary study by Pedroso et al. was supported by FAPEMIG (APq-03539-13). The primary study by Pedroso et al. was supported by Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council (ETT 395). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute. The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR , KRS-144045 & PCG 155468 ). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada . Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre . Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions . The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust , and funding from the Hotchkiss Brain Institute . The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine , and the Hotchkiss Brain Institute . The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania ( LIG-03/2011 ). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958–2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan ( NSC 96-2314-B-182A-090-MY2 ). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland , the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund . The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association . The primary study by De la Torre et al. was supported by a Research Grant “Ram{\'o}n Carrillo-Arturo O{\~n}ativa for Multicentric Studies” (2015) from the commission “Salud Investiga” of the Ministry of Health and Social Action of Argentina (Grant n° 1853 ). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg , and the Adriana van Rinsum-Ponsen Stichting . The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada . The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research ( 01GY1150 ). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network . The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology . The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9–31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL ). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara — SI2.307317 2000CVGG2–026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by H{\"a}rter et al. was supported by the Federal Ministry of Education and Research , the Federation of German Pension Insurance Institutes , and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4 ). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000 ). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea . The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology ( 2009-0087344 ), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by L{\"o}we et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III ( EO PI08/90869 ) and ( PSIGEN-VHC Study : FIS-E08/00268 ). The primary study by Massardo et al. was supported by Comisi{\'o}n Nacional de Investigaci{\'o}n Cient{\'i}fica y Tecnol{\'o}gica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Cient{\'i}fico y Tecnol{\'o}gico (FONDECYT ; grant # 1110849 ). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health ( 16190501 , 19230701 and 20300701 ). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465 ). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain ( PI040418 ) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a {\textquoteleft}start-up{\textquoteright} research grant from the British Geriatric Society, Scotland . The primary study by Reme et al. was supported by the Research Council of Norway . The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund . The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Funda{\c c}ao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM) . The primary study by Azah et al. was supported by Universiti Sains Malaysia . The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance , as well as a studentship from the Canadian Institutes of Health Research . The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106 ). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX ) and of the University of Leipzig (# formel. 1-57 ). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF) . The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne . The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland . The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil . The primary study by Pedroso et al. was supported by FAPEMIG ( APq-03539-13 ). The primary study by Pedroso et al. was supported by Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council ( ETT 395 ). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute . The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = jan,

day = "3",

doi = "10.1016/j.jpsychores.2019.109892",

language = "English",

volume = "129",

journal = "Journal of Psychosomatic Research",

issn = "0022-3999",

publisher = "Elsevier",

}

Wu, Y, Levis, B, Sun, Y, Krishnan, A, He, C, Riehm, KE, Rice, DB, Azar, M, Yan, XW, Neupane, D, Bhandari, PM, Imran, M, Chiovitti, MJ, Saadat, N, Boruff, JT, Cuijpers, P, Gilbody, S , McMillan, D, Ioannidis, JPA, Kloda, LA, Patten, SB, Shrier, I, Ziegelstein, RC, Henry, M, Ismail, Z, Loiselle, CG, Mitchell, ND, Tonelli, M, Al-Adawi, S, Beraldi, A, Braeken, APBM, Büel-Drabe, N, Bunevicius, A, Carter, G, Chen, CK, Cheung, G, Clover, K, Conroy, RM, Cukor, D, da Rocha e Silva, CE, Dabscheck, E, Daray, FM, Douven, E, Downing, MG, Feinstein, A, Ferentinos, PP, Fischer, FH, Flint, AJ, Fujimori, M, Gallagher, P, Gandy, M, Goebel, S, Grassi, L, Härter, M, Jenewein, J, Jetté, N, Julião, M, Kim, JM, Kim, SW, Kjærgaard, M, Köhler, S, Loosman, WL, Löwe, B, Martin-Santos, R, Massardo, L, Matsuoka, Y, Mehnert, A, Michopoulos, I, Misery, L, Navines, R, O'Donnell, ML, Öztürk, A, Peceliuniene, J, Pintor, L, Ponsford, JL, Quinn, TJ, Reme, SE, Reuter, K, Rooney, AG, Sánchez-González, R, Schwarzbold, ML, Senturk Cankorur, V, Shaaban, J, Sharpe, L, Sharpe, M, Simard, S, Singer, S, Stafford, L, Stone, J, Sultan, S, Teixeira, AL, Tiringer, I, Turner, A, Walker, J, Walterfang, M, Wang, LJ, White, J, Wong, DK, Benedetti, A & Thombs, BD 2020, 'Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies', Journal of Psychosomatic Research, vol. 129, 109892. https://doi.org/10.1016/j.jpsychores.2019.109892

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. / Wu, Yin; Levis, Brooke; Sun, Ying et al.
In: Journal of Psychosomatic Research, Vol. 129, 109892, 03.01.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores

T2 - An individual participant data meta-analysis of 73 primary studies

AU - Wu, Yin

AU - Levis, Brooke

AU - Sun, Ying

AU - Krishnan, Ankur

AU - He, Chen

AU - Riehm, Kira E.

AU - Rice, Danielle B.

AU - Azar, Marleine

AU - Yan, Xin Wei

AU - Neupane, Dipika

AU - Bhandari, Parash Mani

AU - Imran, Mahrukh

AU - Chiovitti, Matthew J.

AU - Saadat, Nazanin

AU - Boruff, Jill T.

AU - Cuijpers, Pim

AU - Gilbody, Simon

AU - McMillan, Dean

AU - Ioannidis, John P.A.

AU - Kloda, Lorie A.

AU - Patten, Scott B.

AU - Shrier, Ian

AU - Ziegelstein, Roy C.

AU - Henry, Melissa

AU - Ismail, Zahinoor

AU - Loiselle, Carmen G.

AU - Mitchell, Nicholas D.

AU - Tonelli, Marcello

AU - Al-Adawi, Samir

AU - Beraldi, Anna

AU - Braeken, Anna P.B.M.

AU - Büel-Drabe, Natalie

AU - Bunevicius, Adomas

AU - Carter, Gregory

AU - Chen, Chih Ken

AU - Cheung, Gary

AU - Clover, Kerrie

AU - Conroy, Ronán M.

AU - Cukor, Daniel

AU - da Rocha e Silva, Carlos E.

AU - Dabscheck, Eli

AU - Daray, Federico M.

AU - Douven, Elles

AU - Downing, Marina G.

AU - Feinstein, Anthony

AU - Ferentinos, Panagiotis P.

AU - Fischer, Felix H.

AU - Flint, Alastair J.

AU - Fujimori, Maiko

AU - Gallagher, Pamela

AU - Gandy, Milena

AU - Goebel, Simone

AU - Grassi, Luigi

AU - Härter, Martin

AU - Jenewein, Josef

AU - Jetté, Nathalie

AU - Julião, Miguel

AU - Kim, Jae Min

AU - Kim, Sung Wan

AU - Kjærgaard, Marie

AU - Köhler, Sebastian

AU - Loosman, Wim L.

AU - Löwe, Bernd

AU - Martin-Santos, Rocio

AU - Massardo, Loreto

AU - Matsuoka, Yutaka

AU - Mehnert, Anja

AU - Michopoulos, Ioannis

AU - Misery, Laurent

AU - Navines, Ricard

AU - O'Donnell, Meaghan L.

AU - Öztürk, Ahmet

AU - Peceliuniene, Jurate

AU - Pintor, Luis

AU - Ponsford, Jennie L.

AU - Quinn, Terence J.

AU - Reme, Silje E.

AU - Reuter, Katrin

AU - Rooney, Alasdair G.

AU - Sánchez-González, Roberto

AU - Schwarzbold, Marcelo L.

AU - Senturk Cankorur, Vesile

AU - Shaaban, Juwita

AU - Sharpe, Louise

AU - Sharpe, Michael

AU - Simard, Sébastien

AU - Singer, Susanne

AU - Stafford, Lesley

AU - Stone, Jon

AU - Sultan, Serge

AU - Teixeira, Antonio L.

AU - Tiringer, Istvan

AU - Turner, Alyna

AU - Walker, Jane

AU - Walterfang, Mark

AU - Wang, Liang Jen

AU - White, Jennifer

AU - Wong, Dana K.

AU - Benedetti, Andrea

AU - Thombs, Brett D.

N1 - Funding Information: All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years with the following exceptions: (1) Dr. Patten declares that he has received a grant, from the University of Calgary Hotchkiss Brain Institute, which was jointly funded by the Institute and Pfizer, outside the submitted work. (2) Dr. Ismail declares that he has received personal fees from Avanir, Janssen, Lundbeck, Otsuka, Sunovion, outside the submitted work. (3) Dr. Tonelli declares that he has received a grant from Merck Canada, outside the submitted work. (4) Dr. Feinstein reports that he received speaker's honorariums from Biogen, Sanofi-Genzyme, Merck-Serono, Novartis, Roche, and is on the advisory board for Akili Interactive, outside the submitted work; He has also received royalties from the Cambridge University Press for the Clinical Neuropsychiatry of Multiple Sclerosis, 2nd Edition. (5) Dr. Jetté declares that she has received grants, from University of Calgary Hotchkiss Brain Institute, which was partly funded by Mathison Health Centre and Pfizer, outside the submitted work. (6) Dr. Löwe declares that the primary study by Löwe et al. was supported by unrestricted educational grants from Pfizer, Germany. (7) Dr. Matsuoka declares that he has received personal fees from Mochida, Pfizer, Eli Lilly, Morinaga Milk, and NTT Data, outside the submitted work. (8) Dr. Stone declares that he has received personal fees from UptoDate, outside the submitted work. (9) Dr. Sultan declares funding from Sanofi-Aventis Corporation, during conduct of the primary study. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR, KRS-144045 & PCG 155468). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada. Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre. Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions. The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust, and funding from the Hotchkiss Brain Institute. The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine, and the Hotchkiss Brain Institute. The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania (LIG-03/2011). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958?2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan (NSC 96-2314-B-182A-090-MY2). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland, the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund. The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association. The primary study by De la Torre et al. was supported by a Research Grant ?Ram?n Carrillo-Arturo O?ativa for Multicentric Studies? (2015) from the commission ?Salud Investiga? of the Ministry of Health and Social Action of Argentina (Grant n? 1853). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg, and the Adriana van Rinsum-Ponsen Stichting. The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada. The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research (01GY1150). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network. The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9?31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara ? SI2.307317 2000CVGG2?026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by H?rter et al. was supported by the Federal Ministry of Education and Research, the Federation of German Pension Insurance Institutes, and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea. The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0087344), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by L?we et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III (EO PI08/90869) and (PSIGEN-VHC Study: FIS-E08/00268). The primary study by Massardo et al. was supported by Comisi?n Nacional de Investigaci?n Cient?fica y Tecnol?gica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Cient?fico y Tecnol?gico (FONDECYT; grant # 1110849). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health (16190501, 19230701 and 20300701). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain (PI040418) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a ?start-up? research grant from the British Geriatric Society, Scotland. The primary study by Reme et al. was supported by the Research Council of Norway. The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund. The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Funda?ao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM). The primary study by Azah et al. was supported by Universiti Sains Malaysia. The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance, as well as a studentship from the Canadian Institutes of Health Research. The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX) and of the University of Leipzig (# formel. 1-57). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF). The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne. The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland. The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil. The primary study by Pedroso et al. was supported by FAPEMIG (APq-03539-13). The primary study by Pedroso et al. was supported by Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council (ETT 395). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute. The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards. Funding Information: This study was funded by the Canadian Institutes of Health Research (CIHR , KRS-144045 & PCG 155468 ). Dr. Wu was supported by an Utting Postdoctoral Fellowship from the Jewish General Hospital, Montreal, Quebec, Canada . Ms. Levis was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre . Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates, Health Solutions . The primary study by Scott et al. was supported by the Cumming School of Medicine and Alberta Health Services through the Calgary Health Trust , and funding from the Hotchkiss Brain Institute . The primary study by Amoozegar et al. was supported by the Alberta Health Services, the University of Calgary Faculty of Medicine , and the Hotchkiss Brain Institute . The primary study by Butnoriene et al. was supported by a grant from the Research Concil of Lithuania ( LIG-03/2011 ). Dr. Jurate Butnoriene, PhD, who did the data collection and analysis as part of her PhD thesis for the primary study by Butnoriene et al., passed away and was unable to participate in this project. Dr. Robertas Bunevicius, MD, PhD (1958–2016) was the Principal Investigator of the primary studies by Butnoriene et al. and Bunevicius et al., but passed away and was unable to participate in this project. The primary study by Chen et al. was supported by the National Science Council, Taiwan ( NSC 96-2314-B-182A-090-MY2 ). The primary study by Cheung et al. was supported by the Waikato Clinical School, University of Auckland , the Waikato Medical Research Foundation and the Waikato Respiratory Research Fund . The primary study by Cukor et al. was supported in part by a Promoting Psychological Research and Training on Health-Disparities Issues at Ethnic Minority Serving Institutions Grants (ProDIGs) awarded to Dr. Cukor from the American Psychological Association . The primary study by De la Torre et al. was supported by a Research Grant “Ramón Carrillo-Arturo Oñativa for Multicentric Studies” (2015) from the commission “Salud Investiga” of the Ministry of Health and Social Action of Argentina (Grant n° 1853 ). The primary study by Douven was supported by Maastricht University, Health Foundation Limburg , and the Adriana van Rinsum-Ponsen Stichting . The primary study by Honarmand et al. was supported by a grant from the Multiple Sclerosis Society of Canada . The primary study by Fischer et al. was supported as part of the RECODEHF study by the German Federal Ministry of Education and Research ( 01GY1150 ). The primary study by Gagnon et al. was supported by the Department of Psychiatry, University Health Network . The primary study by Akechi et al. was supported in part by a Grant-in-Aid for Cancer Research (11-2) from the Japanese Ministry of Health, Labour and Welfare and a Grant-in-Aid for Young Scientists (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology . The primary study by Kugaya et al. was supported in part by a Grant-in-Aid for Cancer Research (9–31) and the Second-Term Comprehensive 10-year Strategy for Cancer Control from the Japanese Ministry of Health, Labour and Welfare. The primary study Ryan et al. was supported by the Irish Cancer Society (Grant CRP08GAL ). The primary study by Grassi et al. was supported by the European Commission DG Health and Consumer Protection (Agreement with the University of Ferrara — SI2.307317 2000CVGG2–026), the University of Ferrara, and the Fondazione Cassa di Risparmio di Ferrara. The primary study by Härter et al. was supported by the Federal Ministry of Education and Research , the Federation of German Pension Insurance Institutes , and the Freiburg/Bad Saeckingen Rehabilitation Research Network (Grant 01 GD 9802/4 ). The primary study by Keller et al. was supported by the Medical Faculty of the University of Heidelberg (grant no. 175/2000 ). The primary study by Jang et al. was supported by a grant from the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea . The primary study by Kang et al. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology ( 2009-0087344 ), and was supported by a Grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065). The primary study by Löwe et al. was supported by the medical faculty of the University of Heidelberg, Germany (Project 121/2000). The primary study by Navines et al. was supported in part by grants from the Instituto de Salud Carlos III ( EO PI08/90869 ) and ( PSIGEN-VHC Study : FIS-E08/00268 ). The primary study by Massardo et al. was supported by Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) grant # PFB12/2007 and Fondo Nacional de Desarrolo Científico y Tecnológico (FONDECYT ; grant # 1110849 ). The primary study by Matsuoka et al. was supported by the Japanese Ministry of Health, Labour and Welfare through Research on Psychiatric and Neurological Disease and Mental Health ( 16190501 , 19230701 and 20300701 ). The primary study by Hartung et al. was supported by the German Cancer Aid within the psychosocial oncology funding priority program (grant number 107465 ). The primary study by Consoli et al. was supported by grants from the French Society of Dermatology and the University Hospital of Saint Etienne. Dr. O'Donnell was supported by grants from NHMRC Program (1073041). The primary study by McFarlane et al. was supported by an Australian Government National Health and Medical Research Council program grant. The primary study by Sanchez-Gistau et al. was supported by a grant from the Ministry of Health of Spain ( PI040418 ) and in part by Catalonia Government, DURSI 2009SGR1119. The primary study by Gould et al. was supported by the Transport Accident Commission Grant. The primary study by Lees et al. was supported by a ‘start-up’ research grant from the British Geriatric Society, Scotland . The primary study by Reme et al. was supported by the Research Council of Norway . The primary study by Rooney et al. was supported by the NHS Lothian Neuro-Oncology Endowment Fund . The primary study by Schwarzbold et al. was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundaçao de Amparo a esquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM) . The primary study by Azah et al. was supported by Universiti Sains Malaysia . The primary study by Patel et al. was supported by the University of Sydney Cancer Research Fund. The primary study by Simard et al. was supported by IDEA grants from the Canadian Prostate Cancer Research Initiative and the Canadian Breast Cancer Research Alliance , as well as a studentship from the Canadian Institutes of Health Research . The primary study by Singer et al. was supported by a grant from the German Federal Ministry for Education and Research (no. 01ZZ0106 ). The primary study by Singer et al. was supported by grants from the German Federal Ministry for Education and Research (# 7DZAIQTX ) and of the University of Leipzig (# formel. 1-57 ). The primary study by Meyer et al. was supported by the Federal Ministry of Education and Research (BMBF) . The primary study by Stafford et al. was supported in part by seed funding from the Western and Central Melbourne Integrated Cancer Service. The primary study by Stafford et al. was supported by the University of Melbourne . The primary study by Stone et al. was supported by the Medical Research Council, UK and Chest Heart and Stroke, Scotland . The primary study by de Oliveira et al. was supported by CNPq and Fapemig, Brazil . The primary study by Pedroso et al. was supported by FAPEMIG ( APq-03539-13 ). The primary study by Pedroso et al. was supported by Fundação de Amparo à Pesquisa do Estado de Minas Gerais (Fapemig) (APq-03539-13). The primary study by Tiringer et al. was supported by the Hungarian Research Council ( ETT 395 ). The primary study by Turner et al. was supported by a bequest from Jennie Thomas through Hunter Medical Research Institute . The primary study by Walterfang et al. was supported by Melbourne Health. Drs. Benedetti and Thombs were supported by FRQS researcher salary awards. Publisher Copyright: © 2019 Elsevier Inc.

PY - 2020/1/3

Y1 - 2020/1/3

N2 - Objective: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Methods: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. Results: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). Conclusion: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.

AB - Objective: Two previous individual participant data meta-analyses (IPDMAs) found that different diagnostic interviews classify different proportions of people as having major depression overall or by symptom levels. We compared the odds of major depression classification across diagnostic interviews among studies that administered the Depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Methods: Data accrued for an IPDMA on HADS-D diagnostic accuracy were analysed. We fit binomial generalized linear mixed models to compare odds of major depression classification for the Structured Clinical Interview for DSM (SCID), Composite International Diagnostic Interview (CIDI), and Mini International Neuropsychiatric Interview (MINI), controlling for HADS-D scores and participant characteristics with and without an interaction term between interview and HADS-D scores. Results: There were 15,856 participants (1942 [12%] with major depression) from 73 studies, including 15,335 (97%) non-psychiatric medical patients, 164 (1%) partners of medical patients, and 357 (2%) healthy adults. The MINI (27 studies, 7345 participants, 1066 major depression cases) classified participants as having major depression more often than the CIDI (10 studies, 3023 participants, 269 cases) (adjusted odds ratio [aOR] = 1.70 (0.84, 3.43)) and the semi-structured SCID (36 studies, 5488 participants, 607 cases) (aOR = 1.52 (1.01, 2.30)). The odds ratio for major depression classification with the CIDI was less likely to increase as HADS-D scores increased than for the SCID (interaction aOR = 0.92 (0.88, 0.96)). Conclusion: Compared to the SCID, the MINI may diagnose more participants as having major depression, and the CIDI may be less responsive to symptom severity.

KW - Depressive disorders

KW - Diagnostic interviews

KW - Hospital Anxiety and Depression Scale

KW - Individual participant data meta-analysis

KW - Major depression

UR - http://www.scopus.com/inward/record.url?scp=85077315653&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychores.2019.109892

DO - 10.1016/j.jpsychores.2019.109892

M3 - Article

C2 - 31911325

AN - SCOPUS:85077315653

SN - 0022-3999

VL - 129

JO - Journal of Psychosomatic Research

JF - Journal of Psychosomatic Research

M1 - 109892

ER -

Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE et al. Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. Journal of Psychosomatic Research. 2020 Jan 3;129:109892. Epub 2019 Dec 13. doi: 10.1016/j.jpsychores.2019.109892

Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale – Depression subscale scores: An individual participant data meta-analysis of 73 primary studies

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Cite this